Company / Operating Income per Share
PLIANT THERAPEUTICS, INC. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.75
FY2025
5-year range
-$3.75 / -$0.03
FY2021-FY2025
Trend
-76.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share has fluctuated over the past 6 years, ranging from $-3.75 in FY2025 to $-0.03 in FY2021.
Based on SEC 10-K filings.
-3.75 in FY2025.
Declined from $-1.99 to $-3.75 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 76.8% year-over-year.
- Peak operating income per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.75 | -76.8% |
| FY2024 | -$2.12 | -6.5% |
| FY2023 | -$1.99 | +26.3% |
| FY2022 | -$2.70 | -7706.7% |
| FY2021 | -$0.03 | +94.8% |
| FY2020 | -$0.67 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026